Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics

Laura M. Periman, Darrell E. White, Douglas Katsev

Open source

DOI
10.1007/s40123-024-01076-w
Published
2025-01-07
Container
Ophthalmology and Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40123-024-01076-w,
  title = {Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1\% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics},
  author = {Laura M. Periman and Darrell E. White and Douglas Katsev},
  year = {2025},
  journal = {Ophthalmology and Therapy},
  doi = {10.1007/s40123-024-01076-w},
  url = {https://doi.org/10.1007/s40123-024-01076-w}
}

RIS

TY  - JOUR
TI  - Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics
AU  - Laura M. Periman
AU  - Darrell E. White
AU  - Douglas Katsev
PY  - 2025
JO  - Ophthalmology and Therapy
DO  - 10.1007/s40123-024-01076-w
UR  - https://doi.org/10.1007/s40123-024-01076-w
ER  - 

APA

Periman, L. M., White, D. E., & Katsev, D. (2025). Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics. Ophthalmology and Therapy. https://doi.org/10.1007/s40123-024-01076-w

Source records